fbpx What’s the Deal with Patrick Verheyen? - Blog Post | JLABS

What’s the Deal with Patrick Verheyen?


Today, more than ever, our commitment to delivering innovative healthcare products to patients and consumers means that we must seek and support innovation globally. We are fortunate to live in a time when advances in science and technology continue to enable truly transformational healthcare products that help us to live longer, happier lives. But diseases we are seeking to tackle – like Alzheimer’s disease, diabetes, and cancer – are complex, and that is why having a large global network that connects the best scientific minds, is essential to drive breakthrough new products. This is true whether you are working at the earliest stages of basic research or the final stages of clinical drug development. 
We know that a great idea can come from anywhere. Over the past 2 years, I’ve had the honor of helping to establish Johnson & Johnson Innovation and our regional Innovation Centers. Having led the London Innovation Centre, I saw first-hand, the richness and diversity of the European life science ecosystem. The collaborations we established and continue to advance were uncovered in part through a strategy of proximity – having our scientific and business experts on the ground and working on a day-to-day basis with our external collaborators to help nurture and advance incredibly exciting science that we hope will enable new products.
We earn and maintain the privilege of working with our collaborators by being flexible, transparent and accountable. It’s this approach that I’m excited to bring to my new role as Global Head of Janssen Business Development. While my team and I work with big pharma partners and established biotechs and in general look for later stage licensing and acquisition opportunities than our innovation center colleagues, I believe the principles of flexibility and creativity and spirit of collaboration are the same. 
So for me, it’s not about the deal.  We want to give breakthrough new products ideas the support they need and every advantage to succeed. We depend on partnerships to realize our vision of eliminating disease for people around the world. Achieving this means working beyond the deal to ensuring the right team, with the right incentive and commitment is in place and that access to scientific insights and expertise open new possibilities for patients.

By Patrick Verheyen, Global Head, Johnson & Johnson Innovation - Janssen Business Development